Gene · 5449
Papers2,504
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,504
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Gonadotropin-dependent precocious puberty: genetic and clinical characteristics]. | Probl Endokrinol (Mosk) | 2023 | 37448272 | PubTator, text mining | PubMed |
| [Modern concepts of genetic and immunohistochemical features of prolactin-secreting pituitary adenomas]. | Probl Endokrinol (Mosk) | 2023 | 37448246 | PubTator, text mining | PubMed |
| The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review. | Int J Mol Sci | 2023 | 37446128 | PubTator, text mining | PubMed |
| Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis. | Int J Mol Sci | 2023 | 37445988 | PubTator, text mining | PubMed |
| The evolution in pituitary tumour classification: a clinical perspective. | Endocr Oncol | 2023 | 37434652 | PubTator, text mining | PubMed |
| Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset. | J Neurooncol | 2023 | 37418134 | PubTator, text mining | PubMed |
| TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma. | J Exp Clin Cancer Res | 2023 | 37415241 | PubTator, text mining | PubMed |
| A Collision Tumor of Pit-1/SF-1-positive Double Pituitary Adenoma and a Craniopharyngioma Coexisting with Graves' Disease. | NMC Case Rep J | 2023 | 37398916 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts: from basic science to anticancer therapy. | Exp Mol Med | 2023 | 37394578 | PubTator, text mining | PubMed |
| Management of Neonatal Isolated and Combined Growth Hormone Deficiency: Current Status. | Int J Mol Sci | 2023 | 37373261 | PubTator, text mining | PubMed |
| Role of Estrogen and Estrogen Receptor in GH-Secreting Adenomas. | Int J Mol Sci | 2023 | 37373068 | PubTator, text mining | PubMed |
| Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review. | Biomedicines | 2023 | 37371790 | PubTator, text mining | PubMed |
| Prognostic Models in Growth-Hormone- and Prolactin-Secreting Pituitary Neuroendocrine Tumors: A Systematic Review. | Diagnostics (Basel) | 2023 | 37371013 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Tumours of the Central Nervous System in Children: A Comprehensive Review. | Cancers (Basel) | 2023 | 37370764 | PubTator, text mining | PubMed |
| Plurihormonal (TSH-GH-prolactin Secreting) PIT-1-Positive pituitary Macroadenoma/Pituitary Neuroendocrine Tumor (PitNET) Associated with Graves' Disease: A Case Report. | Endocr Metab Immune Disord Drug Targets | 2023 | 37357515 | PubTator, text mining | PubMed |
| The role of particle radiotherapy in the treatment of skull base tumors. | Front Oncol | 2023 | 37350949 | PubTator, text mining | PubMed |
| Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy. | CNS Neurosci Ther | 2023 | 37341156 | PubTator, text mining | PubMed |
| PROKR2 Mutations in Patients with Short Stature Who Have Isolated Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiency | J Clin Res Pediatr Endocrinol | 2023 | 37338295 | PubTator, text mining | PubMed |
| Role of POU1F1 promoting the properties of stemness of gastric carcinoma through ENO1-mediated glycolysis reprogramming. | Kaohsiung J Med Sci | 2023 | 37334727 | PubTator, text mining | PubMed |
| Clinical features and therapeutic outcomes of GH/TSH cosecreting pituitary adenomas: experience of a single pituitary center. | Front Endocrinol (Lausanne) | 2023 | 37324275 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5449/papers?page=16